Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKYL AMINES vs TATVA CHINTAN PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKYL AMINES TATVA CHINTAN PHARMA ALKYL AMINES/
TATVA CHINTAN PHARMA
 
P/E (TTM) x 67.9 77.0 88.1% View Chart
P/BV x 9.3 5.6 164.2% View Chart
Dividend Yield % 0.5 0.2 293.9%  

Financials

 ALKYL AMINES   TATVA CHINTAN PHARMA
EQUITY SHARE DATA
    ALKYL AMINES
Mar-23
TATVA CHINTAN PHARMA
Mar-23
ALKYL AMINES/
TATVA CHINTAN PHARMA
5-Yr Chart
Click to enlarge
High Rs3,4502,649 130.2%   
Low Rs2,1191,606 131.9%   
Sales per share (Unadj.) Rs329.2191.1 172.3%  
Earnings per share (Unadj.) Rs44.720.5 218.1%  
Cash flow per share (Unadj.) Rs53.624.8 215.8%  
Dividends per share (Unadj.) Rs10.002.00 500.0%  
Avg Dividend yield %0.40.1 382.0%  
Book value per share (Unadj.) Rs228.1232.2 98.2%  
Shares outstanding (eoy) m51.1022.17 230.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x8.511.1 76.0%   
Avg P/E ratio x62.2103.7 60.0%  
P/CF ratio (eoy) x52.085.7 60.7%  
Price / Book Value ratio x12.29.2 133.3%  
Dividend payout %22.39.7 229.3%   
Avg Mkt Cap Rs m142,29147,157 301.7%   
No. of employees `000NANA-   
Total wages/salary Rs m687386 178.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m16,8234,236 397.1%  
Other income Rs m13957 242.2%   
Total revenues Rs m16,9624,294 395.1%   
Gross profit Rs m3,431572 600.0%  
Depreciation Rs m45296 472.8%   
Interest Rs m3386 38.6%   
Profit before tax Rs m3,086448 689.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m799-7 -11,285.7%   
Profit after tax Rs m2,287455 502.7%  
Gross profit margin %20.413.5 151.1%  
Effective tax rate %25.9-1.6 -1,637.8%   
Net profit margin %13.610.7 126.6%  
BALANCE SHEET DATA
Current assets Rs m4,9883,136 159.1%   
Current liabilities Rs m3,5232,361 149.2%   
Net working cap to sales %8.718.3 47.6%  
Current ratio x1.41.3 106.6%  
Inventory Days Days693 2,345.5%  
Debtors Days Days56173 770.9%  
Net fixed assets Rs m13,8774,304 322.4%   
Share capital Rs m102222 46.1%   
"Free" reserves Rs m11,5524,926 234.5%   
Net worth Rs m11,6555,148 226.4%   
Long term debt Rs m042 0.0%   
Total assets Rs m18,8657,439 253.6%  
Interest coverage x93.96.2 1,513.0%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.90.6 156.6%   
Return on assets %12.37.3 169.1%  
Return on equity %19.68.8 222.0%  
Return on capital %26.810.3 260.2%  
Exports to sales %21.876.2 28.6%   
Imports to sales %1.456.9 2.5%   
Exports (fob) Rs m3,6673,229 113.6%   
Imports (cif) Rs m2402,409 10.0%   
Fx inflow Rs m3,6673,229 113.6%   
Fx outflow Rs m3562,409 14.8%   
Net fx Rs m3,310820 403.8%   
CASH FLOW
From Operations Rs m2,484278 894.0%  
From Investments Rs m-2,771-1,011 273.9%  
From Financial Activity Rs m80378 21.1%  
Net Cashflow Rs m-207-357 58.0%  

Share Holding

Indian Promoters % 71.8 72.0 99.8%  
Foreign collaborators % 0.1 0.0 -  
Indian inst/Mut Fund % 4.2 16.5 25.2%  
FIIs % 3.0 3.7 83.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 28.0 28.0 100.2%  
Shareholders   192,885 73,730 261.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKYL AMINES With:   PIDILITE INDUSTRIES    SRF    BALAJI AMINES    GHCL    YASHO INDUSTRIES    


More on ALKYL AMINES vs TATVA CHINTAN PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ALKYL AMINES vs TATVA CHINTAN PHARMA Share Price Performance

Period ALKYL AMINES TATVA CHINTAN PHARMA
1-Day 4.58% 0.64%
1-Month 11.97% 10.05%
1-Year -10.17% -24.15%
3-Year CAGR -5.69% -18.71%
5-Year CAGR 42.90% -11.68%

* Compound Annual Growth Rate

Here are more details on the ALKYL AMINES share price and the TATVA CHINTAN PHARMA share price.

Moving on to shareholding structures...

The promoters of ALKYL AMINES hold a 72.0% stake in the company. In case of TATVA CHINTAN PHARMA the stake stands at 72.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ALKYL AMINES and the shareholding pattern of TATVA CHINTAN PHARMA.

Finally, a word on dividends...

In the most recent financial year, ALKYL AMINES paid a dividend of Rs 10.0 per share. This amounted to a Dividend Payout ratio of 22.3%.

TATVA CHINTAN PHARMA paid Rs 2.0, and its dividend payout ratio stood at 9.7%.

You may visit here to review the dividend history of ALKYL AMINES, and the dividend history of TATVA CHINTAN PHARMA.



Today's Market

Sensex Today Ends 89 Points Higher | Telecom Stocks Shine | Cochin Shipyard Surges 13% Sensex Today Ends 89 Points Higher | Telecom Stocks Shine | Cochin Shipyard Surges 13%(Closing)

After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.